2,723 hedge funds and large institutions have $145B invested in Pfizer in 2021 Q2 according to their latest regulatory filings, with 187 funds opening new positions, 1,279 increasing their positions, 997 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

2% more funds holding

Funds holding: 2,6662,723 (+57)

0.55% more ownership

Funds ownership: 65.76%66.31% (+0.55%)

10% less call options, than puts

Call options by funds: $2.23B | Put options by funds: $2.47B

Holders
2,723
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
70
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.23B
Puts
$2.47B
Net Calls
Net Calls Change

Top Buyers

1 +$396M
2 +$359M
3 +$207M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$179M
5
N
Natixis
France
+$173M

Top Sellers

1 -$316M
2 -$292M
3 -$182M
4
Bank of America
Bank of America
North Carolina
-$154M
5
JP Morgan Chase
JP Morgan Chase
New York
-$144M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$223M
77
$220M
78
$218M
79
$214M
80
$213M
81
$210M
82
$208M
83
$205M
84
$194M
85
$191M
86
$190M
87
$189M
88
$188M
89
$188M
90
$186M
91
$176M
92
$170M
93
$168M
94
$168M
95
$168M
96
$167M
97
$165M
98
$163M
99
$163M
100
$161M